Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank67
3Y CAGR+29.4%
5Y CAGR+266.9%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+29.4%/yr
Annual compound
5Y CAGR
+266.9%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
664.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.30M | -32.6% |
| 2024 | $13.81M | -14.5% |
| 2023 | $16.16M | +276.5% |
| 2022 | $4.29M | +11819.4% |
| 2021 | $36000.00 | +157.1% |
| 2020 | $14000.00 | -92.0% |
| 2019 | $176000.00 | - |